This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, Thomas Jefferson University, University System of Maryland. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 3,696 
1 out of 538 
1 out of 2,027 
Years Active: 2025
Title: Innovations of Matthew S Frieman in Vaccine Development
Introduction
Matthew S Frieman is a notable inventor based in Baltimore, MD, who has made significant contributions to the field of vaccine development. His work primarily focuses on creating multivalent vaccines that provide dual protection against rabies virus and coronaviruses. With one patent to his name, Frieman's innovations are aimed at enhancing public health and safety.
Latest Patents
Frieman's patent, titled "Multivalent vaccines for rabies virus and coronaviruses," presents methods and compositions designed to induce an immune response that offers protection against infections from either or both viruses. The patent details a recombinant rabies virus vector that includes a nucleotide sequence encoding at least one immunogenic glycoprotein fragment from a coronavirus. This innovative approach not only aims to prevent infections but also provides therapeutic options for existing infections, addressing symptoms and neutralizing the infecting agents.
Career Highlights
Throughout his career, Matthew S Frieman has worked with prestigious institutions, including the National Institutes of Health, a component of the US Department of Health & Human Services, and Thomas Jefferson University. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research in vaccine technology.
Collaborations
Frieman has collaborated with notable colleagues such as Reed F Johnson and Matthias Johannes Schnell. These partnerships have facilitated the advancement of his research and the development of innovative vaccine solutions.
Conclusion
Matthew S Frieman's contributions to vaccine development, particularly in creating multivalent vaccines for rabies and coronaviruses, highlight his commitment to improving public health. His work exemplifies the importance of innovation in addressing global health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile